130 related articles for article (PubMed ID: 35771689)
1. Design, Synthesis, and Biological Evaluation of Artemisinin-Piperazine-Phosphoramide Mustard Hybrids as Potential Anticancer Agents.
Wei MX; Zhang SS; Sun X; Ji Y; Yang PW; Li XQ
ChemMedChem; 2022 Sep; 17(17):e202200239. PubMed ID: 35771689
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluation of matrine-dithiocarbamate hybrids as potential anticancer agents.
Zhang MW; He Y; Wei MX
Eur J Med Chem; 2023 Jun; 254():115375. PubMed ID: 37084600
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological evaluation of rhein-piperazine-dithiocarbamate hybrids as potential anticancer agents.
Wei MX; Zhou YX; Lin M; Zhang J; Sun X
Eur J Med Chem; 2022 Nov; 241():114651. PubMed ID: 35963130
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of artemisinin-piperazine-furan ether hybrids and evaluation of in vitro cytotoxic activity.
Wei MX; Yu JY; Liu XX; Li XQ; Zhang MW; Yang PW; Yang JH
Eur J Med Chem; 2021 Apr; 215():113295. PubMed ID: 33636536
[TBL] [Abstract][Full Text] [Related]
5. Novel Sophoridine Derivatives Bearing Phosphoramide Mustard Moiety Exhibit Potent Antitumor Activities In Vitro and In Vivo.
Li D; Dai L; Zhao X; Zhi S; Shen H; Yang Z
Molecules; 2018 Aug; 23(8):. PubMed ID: 30082625
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological activities of artemisinin-piperazine-dithiocarbamate derivatives.
Yu JY; Li XQ; Wei MX
Eur J Med Chem; 2019 May; 169():21-28. PubMed ID: 30852384
[TBL] [Abstract][Full Text] [Related]
7. Identification of Novel Artemisinin Hybrids Induce Apoptosis and Ferroptosis in MCF-7 Cells.
Zhong Y; Li ZN; Jiang XY; Tian X; Deng MH; Cheng MS; Yang HL; Liu Y
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555409
[TBL] [Abstract][Full Text] [Related]
8. Discovery of novel dihydroartemisinin-cinnamic hybrids inducing lung cancer cells apoptosis via inhibition of Akt/Bad signal pathway.
Hu Y; Wang Y; Li N; Chen L; Sun J
Bioorg Chem; 2021 Jun; 111():104903. PubMed ID: 33894433
[TBL] [Abstract][Full Text] [Related]
9. Novel artemisinin derivatives with potent anticancer activities and the anti-colorectal cancer effect by the mitochondria-mediated pathway.
Lin L; Lu W; Dai T; Chen H; Wang T; Yang L; Yang X; Liu Y; Sun D
Bioorg Chem; 2021 Jan; 106():104496. PubMed ID: 33288320
[TBL] [Abstract][Full Text] [Related]
10. Novel enmein-type diterpenoid hybrids coupled with nitrogen mustards: Synthesis of promising candidates for anticancer therapeutics.
Gao X; Li J; Wang M; Xu S; Liu W; Zang L; Li Z; Hua H; Xu J; Li D
Eur J Med Chem; 2018 Feb; 146():588-598. PubMed ID: 29407983
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and biological evaluation of artemisinin-indoloquinoline hybrids as potent antiproliferative agents.
Wang L; Świtalska M; Wang N; Du ZJ; Fukumoto Y; Diep NK; Kiguchi R; Nokami J; Wietrzyk J; Inokuchi T
Molecules; 2014 Nov; 19(11):19021-35. PubMed ID: 25412047
[TBL] [Abstract][Full Text] [Related]
12. Artemisinin-isatin hybrids tethered via ethylene linker and their anti-lung cancer activity.
Wang R; Zhang Q; Chen M
Arch Pharm (Weinheim); 2023 Apr; 356(4):e2200563. PubMed ID: 36572639
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of halogen analogs of phosphoramide, isophosphoramide, and triphosphoramide mustards, the cytotoxic metabolites of cyclophosphamide, ifosfamide, and trofosfamide.
Struck RF; Schmid SM; Waud WR
Cancer Chemother Pharmacol; 1994; 34(3):191-6. PubMed ID: 8004750
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of novel ring-contracted artemisinin dimers with potent anticancer activities.
Zhang N; Yu Z; Yang X; Hu P; He Y
Eur J Med Chem; 2018 Apr; 150():829-840. PubMed ID: 29597166
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of quinazoline-phosphoramidate mustard conjugates as anticancer drugs.
Lin S; Li Y; Zheng Y; Luo L; Sun Q; Ge Z; Cheng T; Li R
Eur J Med Chem; 2017 Feb; 127():442-458. PubMed ID: 28092860
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, cytotoxicity and mechanism of novel dihydroartemisinin-coumarin hybrids as potential anti-cancer agents.
Yu H; Hou Z; Tian Y; Mou Y; Guo C
Eur J Med Chem; 2018 May; 151():434-449. PubMed ID: 29649740
[TBL] [Abstract][Full Text] [Related]
17. Dihydroartemisinin-Bile Acid Hybridization as an Effective Approach to Enhance Dihydroartemisinin Anticancer Activity.
Marchesi E; Chinaglia N; Capobianco ML; Marchetti P; Huang TE; Weng HC; Guh JH; Hsu LC; Perrone D; Navacchia ML
ChemMedChem; 2019 Apr; 14(7):779-787. PubMed ID: 30724466
[TBL] [Abstract][Full Text] [Related]
18. Design, Synthesis, and Biological Evaluation of Novel Amyl Ester Tethered Dihydroartemisinin-Isatin Hybrids as Potent Anti-Breast Cancer Agents.
Xu Z; Zhang X; Liu J; Zhao S; Liu J; Zhou W
Chem Biodivers; 2023 Mar; 20(3):e202201257. PubMed ID: 36808231
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of artemisinin derivatives containing fluorine atoms as anticancer agents.
Li S; Li G; Yang X; Meng Q; Yuan S; He Y; Sun D
Bioorg Med Chem Lett; 2018 Jul; 28(13):2275-2278. PubMed ID: 29789258
[TBL] [Abstract][Full Text] [Related]
20. Artemisinin-indole and artemisinin-imidazole hybrids: Synthesis, cytotoxic evaluation and reversal effects on multidrug resistance in MCF-7/ADR cells.
Hu Y; Li N; Zhang J; Wang Y; Chen L; Sun J
Bioorg Med Chem Lett; 2019 May; 29(9):1138-1142. PubMed ID: 30837097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]